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ABSTRACT 
Objective: Optimal disease management is influenced by a solid patient-health provider relationship; which includes trust in the provider. The 
study compares respondents’ trust in pharmacists and physicians for the delivery of drug information. 
Methods: Residents of 3 rural communities in Lebanon, aged 40 and above, were invited to participate in the study, 760 accepted. Participants were 
asked who they trust the most with information about their medication: their physician or their pharmacist. 
Results: Of the total sample, 154 chose the pharmacist as their most trusted source of medication information (20%). Characteristics associated 
with choosing the pharmacist were: being a male (29.3% vs 16.2% p<.001), of younger age (31.5% among<50 y, 18.8% among 50-64 y, and 14.6% 
among 65+years p<.001), single (31.6% vs 21.9% married and 9.3 others, p=0.023), working (39.2% vs15.7% p<.001), and insured (2.3% vs 16.4% 
p=0.048). The multivariate logistic regression model revealed that having a family member with hypertension (OR=1.86 95% 1.23-2.82), or 
cardiovascular (OR=3.39 95%CI 1.55-7.45) increased the likelihood of trusting pharmacists over medical doctor. On the other hand, a self-report of 
cardiovascular disease (OR=0.34 95% CI 0.12-0.95) and taking medication (OR=0.41 95% CI 0.25-0.67) were associated with a decrease in the trust 
in the pharmacist in favor of the physician.  
Conclusion: Although pharmacists are the drug specialists, the majority of the Lebanese rural community residents reported higher trust in their 
physicians with information about their medication(s). 
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INTRODUCTION 
Optimal disease management is strongly influenced by a solid 
patient-health provider relationship [1, 2]. Trust significantly 
impacts medical care outcomes [3]. Trust can be defined as a 
psychological state which consists of a relational notion between 
two people, such as the patient and their physician, pharmacist, or 
nurse; or between a person and an organization, such as the patient 
and a hospital, or a national health service [4].  
The roles of physicians and pharmacists can be clearly defined and 
differentiated in the healthcare system. While the physician’s role 
consists mainly of assessing, diagnosing, and prescribing drugs, the 
pharmacists’ role has evolved over the years from drug dispensing 
and compounding to a patient-centered service. The modern role of 
pharmacists involves identifying potential drug interactions, allergic 
reactions, contraindications, and providing patient education and 
counseling tips [5]. However, some patients still lack a clear 
understanding of the pharmacist’s extended services and continue 
to view the pharmacist as a drug supplier with a role limited to 
dispensing [6]. To note, more patients are still placing their trust in 
physicians rather than pharmacists with regard to medications. In a 
study comparing older adults’ trust in different healthcare 
providers, 80% of respondents reported trusting physicians “a lot” 
with drug effectiveness compared to 66.4% for trusting pharmacists 
[7]. Similarly, in a study assessing patients’ barriers to asking 
pharmacists medication-related questions, 70% of respondents said 
they were unfamiliar with pharmaceutical care monitoring and 
screening services, and 45% said that their higher trust in their 
physician acted as a barrier towards asking their pharmacist drug-
related questions [8].  
This high level of patients’ trust in their physicians is thought to be 
the result of a solid relationship built over a long period of time [9], 
whereas the less consistent relationship that patients have with 
their pharmacists is compounded by the perception that physicians 
know more about their patients’ medical history. This perception 
can largely be attributed to preset hierarchies on the part of 
patients, who viewed physicians as having authority over other 
health practitioners, besides their vast years of education, as an 
indicator of their pristine judgment, in contrast to a lower certainty 
about pharmacists' education [10]. 
Therefore, the aim of this study was to identify factors that explain 
why individuals prefer either physicians or pharmacists for the 
delivery of information about medication. 
MATERIALS AND METHODS 
Study design 
This study was part of a larger study that employed a community 
mapping approach where adults residing in several rural areas of 
Lebanon were screened for chronic disease(s) and consequently 
referred to primary healthcare centers [11, 12]. 
The design was cross-sectional, with data collected from 3 rural 
areas in Lebanon: Kfarkila, Shehabiyah, and Jleela. A questionnaire 
was administered by trained community health workers during 
the summer of 2015. The questionnaire was made of multiple 
sections including general demographic information (age, sex, 
marital status, etc.), family medical history (hypertension, 
diabetes, high cholesterol, or cardiovascular disease), bio-
physiological measurements (height and weight used to calculate 
BMI), medications (categorized into 4 groups: Antihyperglycemics, 
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Antihypertensive, Antihyperlipidemics and Antiplatelets). Finally, 
the questionnaire asked participants to state a trust preference. 
Permitting a single choice, a questionnaire item asked participants 
whom they trust the most for information about medication from 
among physicians, pharmacists, nurses, family or friends, or 
others. 
Statistical analysis 
Data collected were coded and entered into SPSS V.23. Frequency 
and percentage were used to summarize the variables. A small 
percentage of respondents preferred sources other than physicians 
or pharmacists for information about medication, and so were 
excluded from the study’s bivariate and multivariate analyses. The 
bivariate analysis compared differences in proportion in trust 
preference across socio-economical and health factors (i.e. age, 
gender, etc.). The difference in proportion was tested using 
Pearson’s chi-square. Multivariate logistic regression was used to 
determine factors that independently predict preferential trust in 
pharmacists over physicians. Coefficients produced by the logistic 
regression were exponentiated to produce Odds Ratios (OR), and 
Standard Errors (SE) were used to calculate 95% Confidence 
Intervals (CI). All analyses were carried out at the 0.05 significance 
level.  
Ethical approval 
This study was partially funded by the International Development 
Research Center (IDRC) and was approved by the Institutional 
Review Board of the American University of Beirut (AUB-IRB) 
(Protocol number: FHS. SS. 11). 
RESULTS 
A total of 760 participants age above 40 were surveyed. The majority 
were female (60.5%) and were equally distrusted among the 3 age 
groups (31% 40-49 y, 38.2% 50-64 y, and 30.5% 65 and above). The 
majority were married (87.5%), did not work (75.0%), and were 
uninsured (73.8%). Roughly half had an elementary education, and only 
a minority had secondary or higher education (7%). Hypertension was 
the most prevalent chronic condition reported (44.0%), followed by 
diabetes (30.0%), high cholesterol (10.0%), and cardiovascular disease 
(7.5%). In regard to which health provider respondents trusted most in 
giving them information about medication, the majority chose 
physicians (74.1%) followed by pharmacists (20.3%). These results are 
summarized in table 1. Only 5.7 percent of participants chose other 
sources for information about medication. These individuals were 
excluded from the study’s bivariate and multivariate analyses, for which 
the study sample numbered 717. 
 
Table 1: Descriptive characteristics of the sample 
 N % 
Age groups   
<50 238 31.3% 
50-64 290 38.2% 
65+ 232 30.5% 
Gender   
Female 460 60.5% 
Male 300 39.5% 
Marital Status   
Single 39 5.1% 
Married 665 87.5% 
Other 56 7.4% 
Education   
Illiterate 185 24.3% 
Elementary 385 50.7% 
Intermediate/tech 138 18.2% 
Second/university 52 6.8% 
Employment status   
Doesn’t work 578 76.1% 
Work 182 23.9% 
Insurance status   
Not insured 561 73.8% 
Gov related 147 19.3% 
Armed Forces 40 5.3% 
Private 12 1.6% 
Health Status   
DM 231 30.4% 
Hypertension 335 44.1% 
Cholesterol 79 10.4% 
Cardiovascular 57 7.5% 
Who do you trust the most regarding information about your medications    
Pharmacist 154 20.3% 
MD 563 74.1% 
Others* 43 5.7% 
*respondents who reported trusting nurses, family, and friends or other sources for information were excluded from bivariate and multivariate 
analyses. 
 
Table 2 illustrates that age, gender, marital status, employment, and 
insurance status all affected trust preference between pharmacists 
and physicians.  
The younger age group (40-50 y) had a higher trust preference for 
pharmacists than their older counterparts (31.5% among 40-50 y, 
18.8% among 50-64 y, and 14.6% among 65+years p<.001). Males 
were more likely to express a trust preference for pharmacists over 
physicians compared to females (29.3% vs 16.2% p<.001), as well as 
unmarried respondents compared to those who were married 
(31.6% vs 21.9%, p=0.023). Additionally, those who were employed 
had higher levels of trust in pharmacists compared to those who 
were unemployed (39.2% vs. 15.7%, p<.001). Finally, respondents 
without insurance were more likely to report trust towards 
pharmacists than those with insurance plans (16.4% vs. 2.3% 
p=0.048). Table 2 shows the medication trust information 
(pharmacist or physician) by general socioeconomic characteristics. 
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Table 2: Trust preference (pharmacists vs. physician) by respondents’ demographic characteristics (n=717) 
 Most trust in   
Pharmacist MD p-value 
N % N %  
Gender      
Female 70 16.3% 360 83.7%  
Males 84 29.3% 203 70.7% <0.001 
Age group      
<50 70 31.5% 152 68.5%  
50-64 52 18.8% 224 81.2%  
65+ 32 14.6% 187 85.4% <0.001 
Marital status      
Single 12 31.6% 26 68.4%  
Married 137 21.9% 488 78.1%  
Others 5 9.3% 49 90.7% 0.028 
Educational level      
Illiterate 33 19.1% 140 80.9%  
Elementary 77 21.1% 288 78.9%  
Intermediate/tech 35 26.5% 97 73.5%  
Second/uni 9 19.1% 38 80.9% 0.430 
Employment      
Doesn’t work 85 15.7% 456 84.3%  
work 69 39.2% 107 60.8% <0.001 
Insured      
No 123 23.3%% 405 76.7%%  
Yes 31 16.4% 158 83.6%% 0.048 
 
Table 3 illustrates that respondents who reported having any of the four 
chronic diseases listed in the survey (Cholesterol, Cardiovascular 
Disease, Diabetes, Hypertension) demonstrated less trust preference for 
pharmacists than for physicians. Specifically, respondents with high 
cholesterol were the least likely to trust their pharmacists (7.4% vs. 
23.0% of those without, p<.003), followed by those reported to have 
cardiovascular diseases (9.3% vs. 22.5%, p<.023), diabetes (11.2% vs. 
25.9%, p<.001), and hypertension (15.3% vs. 26.5%, p<.001). 
Additionally, respondents with a higher Body Mass Index (BMI) were 
less likely to trust pharmacists over physicians when compared to those 
with a lower BMI (15.9% for the obese group, 27.0% for the overweight 
group and 35.1% for the normal weight group, p<.001). 
  
Table 3: Trust preference (pharmacists vs. physician) by respondents’ health characteristics 
 Most trust in  
Pharmacist MD p-value 
N % N %  
Reported having      
Diabetes      
NO 130 25.9% 372 74.1%  
YES 24 11.2% 191 88.8% <0.001 
Hypertension      
NO 105 26.5% 291 73.5%  
YES 49 15.3% 272 84.7% <0.001 
High Cholesterol      
NO 149 23.0% 500 77.0%  
YES 5 7.4% 63 92.6% 0.003 
Cardiovascular      
NO 149 22.5% 514 77.5%  
YES 5 9.3% 49 90.7% 0.023 
Weight group      
Normal 53 35.1% 98 64.9%  
Overweight 64 27.0% 173 73.0%  
Obese 34 15.9% 180 84.1% <0.001 
 
Table 4 shows that similar to chronic diseases, respondents who 
reported taking medications were less likely to report trust in 
pharmacists over physicians. Specifically, respondents taking 
antihyperglycemics were the least likely to trust their pharmacist 
compared to those who do not take these medications (9.0% vs. 
24.6%, p<.001), followed by respondents who reported taking 
antihypertensives (10.1% vs. 26.1%, p<.001). Differences in trust 
preference observed among those taking antihyperlipidemic and 
antiplatelet medications were not statistically significant. 
Conversely, table 5 shows that having a family member with a 
chronic disease fortifies a trust preference for pharmacists for the 
provision of medication information. This was most prominently 
observed among participants who reported having a family history 
of cardiovascular disease (56.8% vs. 19.6% of those without a family 
history of cardiovascular disease, p<.001), followed by a family 
history of cholesterol (43.3% vs. 20.5% without, p=.003), 
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Table 4: Trust preference (pharmacists vs. physician) by respondents’ medication use 
 Most trust in  
Pharmacist MD p-value 
N % N %  
Antihyperglycemic      
NO 141 24.6% 432 75.4%  
YES 13 9.0% 131 91.0% <0.001 
Antihypertensive      
NO 133 26.1% 377 73.9%  
YES 21 10.1% 186 89.9% <0.001 
Antihyperlipidemic      
NO 151 21.9% 537 78.1%  
YES 3 10.3% 26 89.7% 0.136 
Antiplatelet      
NO 148 22.1% 521 77.9%  
YES 6 12.5% 42 87.5% 0.117 
Any of the above      
NO 126 28.8% 312 71.2%  
YES 28 10.0% 251 90.0% <0.001 
 
Table 5: Respondents most trust pick by family history 
 Most trust in  
Pharmacist MD p-value 
Family history of:  N % N %  
Diabetes      
NO 100 18.9% 429 81.1%  
YES 54 28.7% 134 71.3% 0.005 
Hypertension      
NO 80 16.9% 393 83.1%  
YES 74 30.3% 170 69.7% <0.001 
Cholesterol      
NO 141 20.5% 546 79.5%  
YES 13 43.3% 17 56.7% 0.003 
Cardiovascular      
NO 133 19.6% 547 80.4%  
YES 21 56.8% 16 43.2% <0.001 
 
All factors that were statistically significant at the bivariate level were 
included in the logistic regression, and only those that remained 
statistically significant in the model were retained (table 6). Males were 
twice as likely as females (OR=1.98, 95%CI 1.33-2.95, p=0.001) to prefer 
pharmacists over physicians as their source for information about 
medications. Reporting having cardiovascular disease was the only 
chronic disease that retained significance in the model, with respondents 
reporting the disease 66% less likely to trust pharmacists over 
physicians (OR=0.34, 95%CI 0.12-0.95, p=0.040). Likewise, respondents 
taking any of the 4 major classes of medications (antihyperglycemics, 
antihypertensive, antihyperlipidemic, and antiplatelets) were 59% less 
likely to trust pharmacists over physicians (OR=0.41 95%CI 0.25-0.67 
p<.0010). However, having a family history of hypertension increased 
the likelihood of trusting pharmacists over physicians by 86% (R=1.86% 
95%CI 1.23-2.82 p=0.019), whereas those with a family history of 
cardiovascular diseases were more than 3 times likely to trust 
pharmacists over physicians (OR=3.39, 95%CI 1.55-7.45 p=0.002). 
Finally, obese people were 54% less likely than normal-weight people 
(OR=0.46, 95%CI 0.25-0.84, p=0.010) to trust pharmacists over 
physicians with drug information. 
  
Table 6: Multivariate logistic regression for trust preference in pharmacist over a medical doctor 
Determinants of trust in pharmacist over MD with medication info OR 95% CI p-value 
Gender    
Female (ref) 1.00   
Male 1.98 (1.33–2.95) 0.001 
Reported having Cardiovascular D.    
NO (ref) 1.00   
YES 0.34 (0.12–0.95) 0.040 
Taking Medications*    
NO (ref) 1.00   
YES 0.41 (0.25–0.67) <0.001 
Family History of:     
Hypertension     
NO (ref) 1.00   
YES 1.86 (1.23–2.82) 0.019 
Cardiovascular Disease     
NO (ref) 1.00   
YES 3.39 (1.55–7.45) 0.002 
Weight group    
Normal (ref) 1.00   
Overweigh 0.67 (0.42–1.08) 0.099 
Obese 0.46 (0.25–0.84) 0.010 
*Any of anti-Hyperlipidemic, anti-hyperglycemic, antihypertensive, and antiplatelet  
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DISCUSSION 
Trust is a crucial characteristic of the patient-health professional 
relationship. Indeed, patients who report low levels of trust in their 
physicians were found to be less satisfied with their therapy, less 
likely to follow their physicians’ advice, and showed less 
symptomatic improvement after weeks of treatment [13]. Overall, 
participants of this study were more likely to trust physicians over 
pharmacists when providing drug information. This was consistent 
with findings from Gidman et al. [10]who found that public trust in 
physicians is greater than public trust in pharmacists. Physicians 
create a solid relationship with their patients through 
communication and interpersonal skills including therapeutic 
guidance and counseling tips [14]. However, other studies have 
suggested that patients tend to trust their pharmacists more with 
drug information, approaching them prior to contacting their 
physicians with cost or adherence concerns [15]. Likewise, 
pharmacists can play an important role in safe and efficient use of 
medication, especially for patients with chronic diseases [16, 17], 
such as the use of insulin pen in elderly diabetic patients [18]. 
This study identified specific factors that significantly impacted trust 
preference. For example, older adults, patients who had one or more 
chronic diseases and thus took prescription medications for 
hypertension, hyperlipidemia, diabetes mellitus and/or 
cardiovascular disease, and individuals who were overweight or 
obese, trusted their physician more than their pharmacist with drug 
information. This was consistent with findings from Donohue et al. 
who found that 79.9% of adults aged 65 and above trust physicians 
to provide information about drug effectiveness, compared to 66.4% 
reporting trusting pharmacists [7]. One reason could be the frequent 
visit chronically ill patients pay to the physician clinic. Østbye et al. 
stated that 828 h per year, or 3.5 h a day, were required to provide 
care for chronic diseases. Furthermore, according to the Joint 
National Commission 7 guidelines, patients with uncontrolled 
hypertension are recommended to schedule monthly visits with 
their physicians [19]. Individuals with high BMI are more likely to 
have chronic conditions associated with obesity [20], and this study 
found that obese individuals were more likely than those of normal 
weight to express a trust preference for physicians as their source of 
medication information. In fact, older adults, patients with chronic 
disease(s), taking chronic medications, and overweight or obese 
individuals need more intense monitoring and regular visits with 
their physician. Therefore, they will develop a close relationship 
with their physician, ultimately leading to higher levels of trust [21]. 
The previous result seemingly contrasts with another finding from 
this study. Individuals with a family history of hypertension and 
cardiovascular disease but who are not personally affected by those 
diseases express higher trust preference for pharmacists. According 
to the Association for Psychological Science, perception regarding an 
illness emerges out of beliefs related to its cause, duration, impact 
on self and family members, and how it can be controlled or cured 
[22]. So, it is possible that people see others’ disease as less severe 
compared to when the disease affects them directly; this is why they 
prefer to stick to the pharmacist rather than the physician when 
they need drug information.  
In addition, patients with chronic disease(s) need a continuous 
supply of medication(s). Although these patients have routine 
contact with physicians, family members may obtain their 
medications, and in the process have frequent contact with 
pharmacists [23, 24], therefore developing a strong relationship that 
leads to trusting the pharmacist over the physician when it comes to 
drug information.  
Furthermore, based on the multivariate analysis, the study found 
that males trust pharmacists more than physicians to provide drug 
information when compared to females. This could be due to 
findings that males tend to delay seeking help when becoming ill and 
exhibit “traditional masculine behaviors” of independence and 
assertiveness [25]. In general, males are less likely to admit 
experiencing medical problems and avoid seeking help from their 
doctor [25, 26]. This avoidance behavior may explain why males are 
more likely to trust pharmacists over physicians.  
LIMITATIONS 
The present study has a number of limitations. Firstly, this is a cross-
sectional study where results are only generalizable to rural 
population adults above 40 y of age, as data collection took place 
among rural areas of Lebanon and excluded individuals below 40 y 
of age.  
Secondly, by giving respondents a forced-choice question between 
only pharmacists and physicians, the findings from this study only 
pertain to trust in pharmacists when delivering medication 
information compared to physicians, and not irrespective of 
physicians. The low percentage of respondents who express a trust 
preference for pharmacists does not imply low trust in pharmacists. 
Finally, there wasn’t any tool used to measure trust within 
healthcare professionals such as the Trust in Physician Scale [27, 
28], the Wake Forest Physician Trust Scale [13], the TRUST-Ph scale, 
or the 3-dimensional scale of Benevolence, Technical Competence, 
and Communication [29].  
As this study is a preliminary analysis based on a previous data-set, 
future research should expand the sample size to include younger 
age groups and those living in urban areas. Furthermore, examining 
the underlying reasons as to why individuals trust pharmacists over 
physicians with medication information could further explain the 
differences seen between various groups (males vs. females, those 
taking medication vs. those who are not, etc.).  
CONCLUSION 
To conclude, this study offers insights regarding factors that 
influence trust preference for pharmacists, compared to physicians, 
for receiving medication information. …While the majority of 
participants were more likely to trust physicians over pharmacists, 
demographic variables, health status, medication, and family history 
were shown to significantly affect these levels of trust. In particular, 
a family history of previous diseases was found to most significantly 
reverse this trend. These findings of this study could be of use in 
facilitating and ameliorating patient-pharmacist trust towards 
receiving medication information. Education about pharmacists’ role 
and expertise targeted towards the general public as well as to 
physicians is highly recommended.  
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